| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.98B | 14.18B | 14.49B | 20.03B | 15.84B |
| Gross Profit | 4.31B | 3.07B | 2.44B | 6.51B | 5.22B |
| EBITDA | 3.54B | 2.37B | 1.87B | 4.62B | 3.81B |
| Net Income | 1.60B | 810.80M | 707.79M | 3.86B | 2.07B |
Balance Sheet | |||||
| Total Assets | 23.57B | 20.94B | 21.95B | 24.64B | 21.60B |
| Cash, Cash Equivalents and Short-Term Investments | 5.02B | 2.75B | 3.13B | 5.45B | 5.25B |
| Total Debt | 33.81M | 26.44M | 32.05M | 43.63M | 664.26M |
| Total Liabilities | 3.40B | 3.47B | 5.01B | 6.15B | 5.96B |
| Stockholders Equity | 14.38B | 12.11B | 14.79B | 16.08B | 13.12B |
Cash Flow | |||||
| Free Cash Flow | 2.04B | 278.14M | -536.56M | 1.24B | -43.38M |
| Operating Cash Flow | 3.71B | 2.07B | 1.38B | 5.08B | 3.91B |
| Investing Cash Flow | -1.56B | -1.50B | -2.63B | -2.91B | -4.09B |
| Financing Cash Flow | 385.76M | -648.37M | -1.51B | -1.96B | 999.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$10.49B | -30.98 | -11.33% | ― | 77.67% | -259.39% | |
72 Outperform | HK$21.59B | 10.18 | 11.90% | 0.98% | 1.21% | 108.04% | |
69 Neutral | HK$4.11B | 7.74 | 6.29% | 6.70% | -4.96% | 15.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$1.24B | 7.69 | 7.36% | 2.20% | -7.41% | 65.65% | |
55 Neutral | HK$6.24B | 8.07 | 7.70% | ― | -5.68% | -25.13% | |
54 Neutral | HK$15.28B | 154.69 | 0.46% | 1.16% | -17.38% | 224.44% |